AIDS and Behavior

, 11:161 | Cite as

Assessing Antiretroviral Adherence via Electronic Drug Monitoring and Self-Report: An Examination of Key Methodological Issues

  • Cynthia R. Pearson
  • Jane M. Simoni
  • Peter Hoff
  • Ann E. Kurth
  • Diane P. Martin
Original paper

Abstract

We explored methodological issues related to antiretroviral adherence assessment, using 6 months of data collected in a completed intervention trial involving 136 low-income HIV-positive outpatients in the Bronx, NY. Findings suggest that operationalizing adherence as a continuous (versus dichotomous) variable and averaging adherence estimates over multiple assessment points (versus using only one) explains greater variance in HIV-1 RNA viral load (VL). Self-reported estimates provided during a phone interview accounted for similar variance in VL as EDM estimates (R2 = .17 phone versus .18 EDM). Self-reported adherence was not associated with a standard social desirability measure, and no difference in the accuracy of self-report adherence was observed for assessment periods of 1–3 days. Self-reported poor adherence was more closely associated with EDM adherence estimates than self-reported moderate and high adherence. On average across assessment points, fewer than 4% of participants who reported taking a dose of an incorrect amount of medication.

Keywords

HIV/AIDS HAART Antiretroviral adherence assessment Electronic drug monitoring MEMS Self-report 

References

  1. Ammassari, A., Trotta, M., Murri, R., Castelli, F., Narciso, P., Noto, P. et al. (2002). Correlates and predictors of adherence to highly active antiretroviral therapy: Overview of published literature. Journal of Acquired Immune Deficiency Syndromes, 31, S123–S127.PubMedGoogle Scholar
  2. Arnsten, J. H., Demas, P. A., Farzadegan, H., Grant, R.W., Gourevitch, M. N., Chang, C. J. et al. (2001). Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: Comparison of self-report and electronic monitoring. Clinical Infectious Diseases, 33(8), 1417–1423.PubMedCrossRefGoogle Scholar
  3. Bangsberg, D. R. (2004). U.S. researcher starts treatment fund in Uganda: Interview with David Bangsberg, M.D., M.P.H. AIDS Treatment News (402), 3–5.Google Scholar
  4. Bangsberg, D. R., Bronstone, A., Chesney, M. A., & Hecht, F. M. (2002). Computer-assisted self-interviewing (CASI) to improve provider assessment of adherence in routine clinical practice. Journal of Acquired Immune Deficiency Syndromes, 31(3), S107–S111.PubMedGoogle Scholar
  5. Bangsberg, D. R., Hecht, F. M., Charlebois, E. D., Chesney, M. A., & Moss, A. (2001). Comparing objective measures of adherence to HIV antiretroviral therapy: Electronic medication monitors and unannounced pill counts. AIDS and Behavior, 5, 272–281.CrossRefGoogle Scholar
  6. Bangsberg, D. R., Hecht, F. M., Charlebois, E. D., Zolopa, A. R., Holodniy, M., Sheiner, L. et al. (2000). Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS, 14, 357–366.Google Scholar
  7. Bangsberg, D. R., Hecht, F. M., Clague, H., Charlebois, E. D., Ciccarone, D., Chesney, M. et al. (2001). Provider assessment of adherence to HIV antiretroviral therapy. Journal of Acquired Immune Deficiency Syndrome, 26(5), 435–442.Google Scholar
  8. Bova, C. A., Fennie, K. P., Knafl, G. J., Dieckhaus, K. D., Watrous, E., & Williams, A. B. (2005). Use of electronic monitoring devices to measure antiretroviral adherence: Practical considerations. AIDS and Behavior, 9(1), 103–110.PubMedCrossRefGoogle Scholar
  9. Chesney, M. (1999). The challenge of adherence. Bulletin of Experimental Treatments for AIDS, 12(1), 10–13.PubMedGoogle Scholar
  10. Chesney, M. A., Ickovics, J. R., Chambers, D. B., Gifford, A. L., Neidig, J., Zwickl, B. et al. (2000). Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG adherence instruments. Patient Care Committee and Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care, 12(3), 255–266.PubMedCrossRefGoogle Scholar
  11. Crowne, D., & Marlow, D. (1964). Social desirability scale. In the approval motive. John Wiley and Sons Inc.: New York.Google Scholar
  12. Deschamps, A. E., Graeve, V. D., van Wijngaerden, E., De Saar, V., Vandamme, A. M., van Vaerenbergh, K. et al. (2004). Prevalence and correlates of nonadherence to antiretroviral therapy in a population of HIV patients using Medication Event Monitoring System. AIDS Patient Care and STDS, 18(11), 644–657.PubMedCrossRefGoogle Scholar
  13. Di Matteo, M. R., Hays, R. D., & Gritz, E. R. (1993). Patient adherence to cancer control regimens: Scale development and initial validation. Psychological Assessment, 5, 101–112.CrossRefGoogle Scholar
  14. Dunbar-Jacob, J., & Schlenk, E. (2001). Patient adherence to treatment regimen. In A. Baum, T. A. Revenson, & J. E. Singer (Eds.), Handbook of health psychology (pp. 571–580). Mahwah: NJ.Google Scholar
  15. Duong, M., Piroth, L., Peytavin, G., Forte, F., Kohli, E., Grappin, M. et al. (2001). Value of patient self-report and plasma human immunodeficiency virus protease inhibitor level as markers of adherence to antiretroviral therapy: relationship to virologic response. Clinical Infectious Diseases, 33(3), 386–392 Epub 2001 Jun 2021.PubMedCrossRefGoogle Scholar
  16. Gao, X., & Nau, D. P. (2000). Congruence of three self-report measures of medication adherence among HIV patients. Annals of Pharmacotherapy, 34(10), 1117–1122.PubMedGoogle Scholar
  17. Golin, C. E., Liu, H., Hays, R. D., Miller, L. G., Beck, C. K., Ickovics, J. et al. (2002). A prospective study of predictors of adherence to combination antiretroviral medication. Journal of General Internal Medicine, 17(10), 756–765.PubMedCrossRefGoogle Scholar
  18. Howard, A. A., Arnsten, J. H., Lo, Y., Vlahov, D., Rich, J. D., Schuman, P., Stone, V. E. et al. (2002). A prospective study of adherence and viral load in a large multi-center cohort of HIV-infected women. AIDS, 16(16), 2175–2182.PubMedCrossRefGoogle Scholar
  19. Hugen, P.W., Burger, D. M., Aarnoutse, R. E., Baede, P. A., Nieuwkerk, P. T., Koopmans, P. P., & Hekster, Y. A. (2002). Therapeutic drug monitoring of HIV-protease inhibitors to assess noncompliance. Theraputic Drug Monitoring, 24(5), 579–587.CrossRefGoogle Scholar
  20. Hugen, P. W., Langebeek, N., Burger, D. M., Zomer, B., van Leusen, R., Schuurman, R. et al. (2002). Assessment of adherence to HIV protease inhibitors: Comparison and combination of various methods, including MEMS (electronic monitoring), patient and nurse report, and therapeutic drug monitoring. Journal of Acquired Immune Deficiency Syndrome, 30(3), 324–334.Google Scholar
  21. Johnson, R. L., Botwinick, G., Sell, R. L., Martinez, J., Siciliano, C., Friedman, L. B. et al. (2003). The utilization of treatment and case management services by HIV-infected youth. Journal of Adolescent Health, 33(2 Suppl), 31–38.PubMedCrossRefGoogle Scholar
  22. Kalichman, S. C., Cain, D., Fuhrel, A., Eaton, L., Di Fonzo, K., & Ertl, T. (2005). Assessing medication adherence self-efficacy among low-literacy patients: development of a pictographic visual analogue scale. Health Education Research, 20(1), 24–35.PubMedCrossRefGoogle Scholar
  23. Kimmerling, M., Wagner, G., & Ghosh-Dastidar, B. (2003). Factors associated with accurate self-reported adherence to HIV antiretrovirals. International Journal of STD and AIDS, 14(4), 281–284.PubMedCrossRefGoogle Scholar
  24. Knobel, H., Guelar, A., Carmona, A., Espona, M., Gonzalez, A., Lopez-Colomes, J. L. et al. (2001). Virologic outcome and predictors of virologic failure of highly active antiretroviral therapy containing protease inhibitors. AIDS Patient Care and STDs, 15, 193–199.PubMedCrossRefGoogle Scholar
  25. Lievens, F. (2002). Trying to understand the different pieces of the construct validity puzzle of assessment centers: An examination of assessor and assessee effects. Journal of Applied Psychology, 87(4), 675–686.PubMedCrossRefGoogle Scholar
  26. Liu, H., Golin, C. E., Miller, L. G., Hays, R. D., Beck, C. K., Sanandaji, S. et al. (2001). A comparison study of multiple measures of adherence to HIV protease inhibitors. Annals of Internal Medicine, 134(10), 968–977.PubMedGoogle Scholar
  27. Llabre, M. M., Weaver, K. E., Durán, R. E., Antoni, M. H., McPherson-Baker, S., Klimas, N. et al. (2006). A measurement model of medication adherence to highly active antiretroviral therapy and its relation to viral load in HIV+ Adults. AIDS Care and STD.Google Scholar
  28. Melbourne, K. M., Geletko, S. M., Brown, S. L., Willey-Lessne, C., Chase, S., & Fisher, A. (1999). Medication adherence in patients with HIV infection: A comparison of two measurement methods. AIDS Read, 9(5), 329–338.PubMedGoogle Scholar
  29. Miller, L. G., & Hays, R. D. (2000a). Adherence to combination antiretroviral therapy: Synthesis of the literature and clinical implications. The AIDS Reader, 10(3), 177–185.Google Scholar
  30. Miller, L. G., & Hays, R. D. (2000b). Measuring adherence to antiretroviral medications in clinical trials. HIV Clinical Trials, 1(1), 36–46.CrossRefGoogle Scholar
  31. Morisky, D. E., Green, L. W., & Levine, D. M. (1986). Concurrent and predictive validity of a self-reported measure of medication adherence. Medical Care, 24(1), 76–74.CrossRefGoogle Scholar
  32. Murri, R., Ammassari, A., Gallicano, K., De Luca, A., Cingolani, A., Jacobson, D. et al. (2000). Patient-reported nonadherence to HAART is related to protease inhibitor levels. Journal of Acquired Immunodeficiency Syndromes, 24(2), 123–128.Google Scholar
  33. Nieuwkerk, P. T. (2003). Electronic monitoring of adherence to highly active antiretroviral therapy changes medication-taking behaviour? AIDS, 17(9), 1417–1418.PubMedCrossRefGoogle Scholar
  34. Nieuwkerk, P. T., & Oort, F. J. (2005). Self-reported adherence to antiretroviral therapy for HIV-1 infection and virologic treatment response: a meta-analysis. Journal of Acquired Immune Deficiency Syndromes, 38(4), 445–448.PubMedCrossRefGoogle Scholar
  35. Osterberg, L., & Blaschke, T. (2005). Adherence to medication. New England Journal of Medicine, 353(5), 487–497.PubMedCrossRefGoogle Scholar
  36. Oyugi, J. H., Byakika-Tusiime, J., Charlebois, E. D., Kityo, C., Mugerwa, R., Mugyenyi, P. et al. (2004). Multiple validated measures of adherence indicate high levels of adherence to generic HIV antiretroviral therapy in a resource-limited setting. Journal of Acquired Immune Deficiency Syndromes, 36(5), 1100–1102.PubMedCrossRefGoogle Scholar
  37. Parienti, J. J., Verdon, R., Bazin, C., Bouvet, E., Massari, V., & Larouze, B. (2001). The pills identification test: A tool to assess adherence to antiretroviral therapy. JAMA, 285(4), 412.PubMedCrossRefGoogle Scholar
  38. Paterson, D., Potoski, B., & Capitano, B. (2002). Measurement of adherence to antiretroviral medications. Journal of Acquired Immune Deficiency Syndromes, 31, S103–S106.PubMedGoogle Scholar
  39. Paterson, D., Swindells, S., Mohr, J., Brester, M., Vergis, E., Squier, C. et al. (2000). Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine, 133(1), 21–30.PubMedGoogle Scholar
  40. Reynolds, N. R. (2004). Adherence to antiretroviral therapies: State of the science. Current HIV Research, 2(3), 207–214.PubMedCrossRefGoogle Scholar
  41. Rogers, S. M., Willis, G., Al-Tayyib, A., Villarroel, M. A., Turner, C. F., Ganapathi, L. et al. (2005). Audio computer assisted interviewing to measure HIV risk behaviours in a clinic population. Sexually Transmitted Infections, 81(6), 501–507.PubMedCrossRefGoogle Scholar
  42. Rudd, P., Byyny, R. L., Zachary, V., LoVerde, M. E., Mitchell, W. D., Titus, C. et al. (1988). Pill count measures of compliance in a drug trial: Variability and suitability. American Journal of Hypertension, 1(3 Pt 1), 309–312.PubMedGoogle Scholar
  43. Samet, J. H., Sullivan, L. M., Traphagen, E. T., & Ickovics, J. R. (2002). Measuring adherence among HIV-infected persons: Is MEMS consummate technology? AIDS and Behavior, 5(1), 21–30.CrossRefGoogle Scholar
  44. Sankar, A., Neufeld, S., Nevedal, D., & Luborsky, M. (2006). What is a missed dose? Implications or construct validity and patient adherence. AIDS Care.Google Scholar
  45. Simoni, J. M., Frick, P.A., & Huang, B. (2006). A longitudinal evaluation of a social support model of medication adherence among HIV-positive men and women on antiretroviral therapy. Health Psychology, 25, 74–81.PubMedCrossRefGoogle Scholar
  46. Simoni, J. M., Frick, P. A., Pantalone, D. W., & Turner, B. J. (2003). Antiretroviral adherence interventions: A review of current literature and ongoing studies. Topics in HIV Medicine, 11(6), 185–198.PubMedGoogle Scholar
  47. Simoni J. M., Kurth A., Pearson C. R., Pantalone D. W., Merrill J., & Frick P. A. (2006). A review of self-report measures of HIV antiretroviral adherence. AIDS and Behavior.Google Scholar
  48. Simoni, J. M., Pantalone, D. W., Plummer, M. D., & Huang, B. (in press). A randomized controlled trial of a peer support intervention to improve antiretroviral adherence and decrease depressive symptomatology among HIV-positive individuals. Health Psychology. Google Scholar
  49. Streiner, D. L. (2002). Breaking up is hard to do: the heartbreak of dichotomizing continuous data. Canadian Journal of Psychiatry, 47(3), 262–266.Google Scholar
  50. Turner, B. (2002). Adherence to antiretroviral therapy by human immunodeficiency virus-infected patients. The Journal of Infectious Diseases, 185 (Suppl 2), S143–151.PubMedCrossRefGoogle Scholar
  51. Turner, B. J., & Hecht, F. M. (2001). Improving on a coin toss to predict patient adherence to medications. Annals of Internal Medicine, 134(10), 1004–1006.PubMedGoogle Scholar
  52. Wagner, G., & Miller, L. G. (2004). Is the influence of social desirability on patients’ self-reported adherence overrated? Journal of Acquired Immune Deficiency Syndromes, 35(2), 203–204.PubMedCrossRefGoogle Scholar
  53. Wagner, G. J. (2003). Does discontinuing the use of pill boxes to facilitate electronic monitoring impede adherence? International Journal of STD and AIDS, 14(1), 64–65.PubMedCrossRefGoogle Scholar
  54. Wagner, G. J., Kanouse, D. E., Koegel, P., & Sullivan, G. (2003). Adherence to HIV antiretrovirals among persons with serious mental illness. AIDS Patient Care STDS, 17(4), 179–186.PubMedCrossRefGoogle Scholar
  55. Wagner, G. J., & Rabkin, J. G. (2000). Measuring medication adherence: Are missed doses reported more accurately then perfect adherence? AIDS Care, 12(4), 405–408.PubMedCrossRefGoogle Scholar
  56. Walsh, J. C., Horne, R., Dalton, M., Burgess, A. P., & Gazzard, B. G. (2001). Reasons for non-adherence to antiretroviral therapy: patients’ perspectives provide evidence of multiple causes. AIDS Care, 13(6), 709–720.PubMedCrossRefGoogle Scholar
  57. Walsh, J. C., Mandalia, S., & Gazzard, B. G. (2002). Responses to a 1 month self-report on adherence to antiretroviral therapy are consistent with electronic data and virological treatment outcome. AIDS, 16(2), 269–277.PubMedCrossRefGoogle Scholar
  58. Wendel, C. S., Mohler, M. J., Kroesen, K., Ampel, N. M., Gifford, A. L., & Coons, S. J. (2001). Barriers to use of electronic adherence monitoring in an HIV clinic. Annals of Pharmacotherapy, 35(9), 1010–1015.PubMedCrossRefGoogle Scholar
  59. Wewers, M. E., & Lowe, N. K. (1990). A critical review of visual analogue scales in the measurement of clinical phenomena. Res Nurs Health, 13(4), 227–236.PubMedCrossRefGoogle Scholar
  60. Wutoh, A., Elekwachi, O., Clarke-Tasker, V., Daftary, M., Powell, N., & Campusano, G. (2003). Assessment and predictors of antiretroviral adherence in older HIV-infected patients. Journal of Acquired Immune Deficiency Syndromes, 33(2), S106–S114.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, Inc. 2006

Authors and Affiliations

  • Cynthia R. Pearson
    • 1
    • 2
  • Jane M. Simoni
    • 2
  • Peter Hoff
    • 3
  • Ann E. Kurth
    • 4
    • 5
  • Diane P. Martin
    • 1
  1. 1.Department of Health Services, School of Public Health and Community MedicineUniversity of WashingtonSeattleUSA
  2. 2.Department of PsychologyUniversity of WashingtonSeattleUSA
  3. 3.Department of StatisticsUniversity of WashingtonSeattleUSA
  4. 4.School of NursingUniversity of WashingtonSeattleUSA
  5. 5.Center for AIDS ResearchUniversity of WashingtonSeattleUSA

Personalised recommendations